MD Anderson and UT Austin launch joint initiative to advance breakthroughs in cancer research
The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the Collaborative Accelerator for Transformative Research Endeavors, to enable groundbreaking research projects that align complementary strengths to improve cancer prevention, diagnosis, treatment and survival.
The two institutions announced that the Accelerator program has awarded funding to five teams to...

UT MD Anderson and Texas Children’s Hospital Announce Joint Venture to End Childhood Cancer
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital have announced a transformational collaboration dedicated...
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the...
MD Anderson’s Lauren Averett Byers receives TAMEST O’Donnell Award for seminal contributions to lung cancer research
Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, has received the 2025 Edith and Peter O’Donnell Award in Medicine from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST). The award recognizes her fundamental discoveries and contributions to identifying novel therapeutic strategies for small cell lung cancer (SCLC), which...

MD Anderson and AmMax Bio announce agreements to advance development of AMB-066 in colorectal cancer patients with minimal residual disease
The University of Texas MD Anderson Cancer Center and AmMax Bio, Inc. today announced a worldwide exclusive license agreement and clinical...
MD Anderson statement on BCBS TX ending Medicare Advantage and Medicaid plans
Blue Cross Blue Shield notified The University of Texas MD Anderson Cancer Center it will end its Letter of Agreement for Medicare Advantage...
Allison Institute scientific symposium features spatial biology breakthroughs, $5 million gift to support further efforts
The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center hosted its second annual scientific...
MD Anderson and Summit Therapeutics announce strategic collaboration to accelerate development of ivonescimab
The University of Texas MD Anderson Cancer Center and Summit Therapeutics, Inc. today announced a strategic five-year collaboration agreement...
MD Anderson and Rice launch Cancer Bioengineering Collaborative
The University of Texas MD Anderson Cancer Center and Rice University today announced the creation of the Cancer Bioengineering Collaborative...
MD Anderson Research Highlights: EHA 2024 Special Edition
ABSTRACTS: LB3439, LB3442, S131, S132, S136, S164, S222
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases...